Arena Pharma (ARNA) Moves Higher; Sees European Belviq Approval in H113, All Debt Prepaid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Obesity Drug Makers Gears Up for Busy Sept. Conference Schedule (ARNA) (OREX) (VVUS)
September 4, 2012 10:39 AM EDTLike pharmaceutical conferences? Also enjoy companies that produce newly-approved obesity-control drugs? Then, have we got a list for you!
Below is a brief schedule of events coming up for the three big players in weight-loss pill technology: Orexigen (Nasdaq: OREX), VIVUS (Nasdaq:... More
